Conference Coverage
Conference Coverage
Lupus may confer higher risk for cervical cancer
Key clinical point: Women with SLE should be encouraged to be screened for cervical cancer, particularly those treated with immunosuppressive...
Conference Coverage
Tandem beats single ASCT for childhood neuroblastoma
Key clinical point: Neuroblastoma event-free survival was better with tandem than with single ASCT. Major finding: Event-free survival was 61%...
Conference Coverage
Daratumumab yields “unprecedented” PFS benefit in refractory myeloma
Key clinical point: Daratumumab improves outcomes when added to the current standard of care in relapsed or refractory myeloma. Major finding:...
Conference Coverage
Venetoclax + LDAC has potential in older AML patients
CHICAGO—Investigators are pursuing the combination of the selective BCL-2 inhibitor venetoclax plus low-dose cytarabine (LDAC) in older, treatment...
Conference Coverage
Gyn. oncologists are in demand for robotic hysterectomy
Key clinical point: Gynecologic oncologists achieved better robotic hysterectomy outcomes than gynecologists despite challenging referrals. Major...
Conference Coverage
IL-2 adds only toxicity to neuroblastoma antibody tx
Key clinical point: IL-2 adds no benefit, only toxicity, to neuroblastoma antibody therapy. Major finding: Only 61% of treatment cycles were...
Conference Coverage
Maintenance rituximab extends progression-free but not overall survival in CLL
Key clinical point: Progression-free survival, but not overall survival, was improved after 2 years of maintenance immunotherapy with rituximab....
Conference Coverage
Rituximab plus chemo in kids with B-NHL could be practice changing
© ASCO/Matt Herp CHICAGO—The first interim analysis of rituximab plus chemotherapy in children and adolescents with high-risk B-cell non-Hodgkin...
Conference Coverage
Liquid biopsies prove useful alternative to tissue biopsies
Liquid biopsy, the testing of the blood for circulating tumor DNA (ctDNA), identified cancer mutations useful as biomarkers – many associated with...
Conference Coverage
Anticlaudin antibody increases survival in advanced gastric cancer
Key clinical point: A novel monoclonal antibody in combination with chemotherapy increased overall and progression-free survival in advanced...
Conference Coverage
Hispanic, black AYA more likely to die of their cancer
© ASCO/Zach Boyden-Holmes CHICAGO—Hispanic white and non-Hispanic black adolescents and young adults (AYA) are more likely to die of their...